Our clinical studies
Our contribution to clinical research
Our contribution to clinical research
2023
Real-life study
Rheumatology
T. Pretat, et al. Effects of virtual reality in patients with chronic refractory pain syndromes undergoing a multimodal pain program – N=201
BMJ Journals, 2023.
- 51% of patients experienced a reduction of pain
- 49% of patients experienced a reduction of anxiety
- 76% rated the overall experience with VR as positive
Real-life study
Rheumatology
T. Pretat, et al. Effects of virtual reality in patients with chronic refractory pain syndromes undergoing a multimodal pain program – N=201
BMJ Journals, 2023.
- 51% of patients experienced a reduction of pain
- 49% of patients experienced a reduction of anxiety
- 76% rated the overall experience with VR as positive
2022
Randomised controlled trial
Reanimation
L. Merliot‐Gailhoustet, et al. Improving the discomfort of critically ill patients with electronic relaxation devices – N=60
Critical Care, 2022.
- -50% discomfort
- +24 point ANI-score
Randomised controlled trial
Reanimation
L. Merliot‐Gailhoustet, et al. Improving the discomfort of critically ill patients with electronic relaxation devices – N=60
Critical Care, 2022.
- -50% discomfort
- +24 point ANI-score
Prospective, interventional feasibility study
Emergency
T. Birrenbach, et al. Virtual reality to relieve pain in the emergency room – N=52
BMC Emergency Medecine, 2022.
- -33% pain
- -50% anxiety
Prospective, interventional feasibility study
Emergency
T. Birrenbach, et al. Virtual reality to relieve pain in the emergency room – N+52
BMC Emergency Medecine, 2022.
- -33% pain
- -50% anxiety
Randomised crossover pilot study
Quality of life at work
L. Bodet-Contentin, et al. Virtual reality during work breaks to reduce caregiver fatigue in intensive care units – N=88
Australian Critical Care, 2022.
- -48% fatigue
- +30% disconnection
Randomised crossover pilot study
Quality of life at work
L. Bodet-Contentin, et al.Virtual reality during work breaks to reduce caregiver fatigue in intensive care units – N=88
Australian Critical Care, 2022.
- -48% fatigue
- +30% disconnection
pilot study
Cardiology
C. Brown, et al.Virtual reality – a new addition to the anxiolytic array for cardiac device implantation – N=17
The Allan Lab Immersive, 2022.
- -39% pain
- -14% anxiolytic
pilot study
Cardiology
C. Brown, et al.Virtual reality – a new addition to the anxiolytic array for cardiac device implantation – N=17
The Allan Lab Immersive, 2022.
- -39% pain
- -14% anxiolytic
Real-Life study
Neurology
K. Hill, et al. Virtual reality device to improve tolerance of lumbar puncture – N=1
BMJ Neurology Open, 2022.
- Reduction in the amount of pharmacological therapy required
- Alternative/complement to sedation and analgesia
Real-Life study
Neurology
K. Hill, et al. Virtual reality device to improve tolerance of lumbar puncture – N=1
BMJ Neurology Open, 2022.
- Reduction in the amount of pharmacological therapy required
- Alternative/complement to sedation and analgesia
Prospective randomised study
Dental care
A. Protin, et al. Investigating the impact of virtual reality on anxiety during dental avulsions under local anaesthesia – N=119
Thesis – Faculté de Médecine de Caen, 2022.
- +20% with -8 points anxiety STAI-YA
- 96% wish to do it again
Prospective randomised study
Dental care
A. Protin, et al. Investigating the impact of virtual reality on anxiety during dental avulsions under local anaesthesia – N=119
Thesis – Faculté de Médecine de Caen, 2022.
- +20% with -8 points anxiety STAI-YA
- 96% wish to do it again
Pilot study
Emergency
H. Goulet, et al. Evaluation of virtual reality to avoid morphin in treatment of vaso-occlusive crises in sickle-cell patients in the emergency department – N=97
SMFU, 2022.
- -26% morphine
- 4 of 5 satisfaction
Pilot study
Emergency
H. Goulet, et al.Evaluation of virtual reality to avoid morphin in treatment of vaso-occlusive crises in sickle-cell patients in the emergency department – N=97
SMFU, 2022.
- -26% morphine
- 4 of 5 satisfaction
2021
Prospective study
Paediatrics
R. Assaker, et al. Effectiveness of virtual reality in reducing anxiety and pain during paediatric idiopathic scoliosis surgery – N=43
SFAR, 2021.
- -33% anxiety
- -83% morphine
Prospective study
Paediatrics
R. Assaker, et al.Effectiveness of virtual reality in reducing anxiety and pain during paediatric idiopathic scoliosis surgery – N=43
SFAR, 2021.
- -33% anxiety
- -83% morphine
2020
Prospective study
Palliative care
Erwan G. & Yves C. The contribution of therapeutic virtual reality to pain and anxiety management in palliative care day care
Maison Pallia-vie, 2020.
- -70% pain
- -70% anxiety
Prospective study
Palliative care
Erwan G. & Yves C. The contribution of therapeutic virtual reality to pain and anxiety management in palliative care day care
Maison Pallia-vie, 2020.
- -70% pain
- -70% anxiety
2019
Prospective study
Paediatrics
L. Marsac, et al. Evaluation of a virtual reality headset in the prevention of peri-operative anxiety in children – N=15
SFAR, 2019.
- -57% anxiety children & parents
Prospective study
Paediatrics
L. Marsac, et al. Evaluation of a virtual reality headset in the prevention of peri-operative anxiety in children – N=15
SFAR, 2019.
- -57% anxiety children & parents
Real-Life study
Nursing home
G. Pisica, et al. Virtual Reality (Healthy Mind®) in EHPAD: Evaluation in elderly people with cognitive disorders – N=14
JASFGG, 2019. N = 14
- 78% acceptation
Real-Life study
Nursing home
G. Pisica, et al. Virtual Reality (Healthy Mind®) in EHPAD: Evaluation in elderly people with cognitive disorders – N=14
JASFGG, 2019.
- 78% acceptation
Interested in one of our studies?
If you want to know more about our clinical studies, please contact us with the subject of your request
If you are interested to set up a clinical study, you can also contact us to discuss it
Interested in one of our studies?
If you want to know more about our clinical studies, please contact us with the subject of your request
If you are interested to set up a clinical study, you can also contact us to discuss it
